$1.17
-0.03-2.50%
At close: -
$1.20
0.032.56%
After Hours: Feb 21, 8:06 AM EDT
Comments
Loading...
Citius Oncology (NASDAQ:CTOR) Stock, Earnings Estimates, EPS, And Revenue
Citius Oncology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 14
EPS
$-0.090
Quarterly Revenue
$0.00
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Citius Oncology using advanced sorting and filters.
Data brought to you by Benzinga APIs
Citius Oncology (CTOR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Citius Oncology (CTOR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Citius Oncology (NASDAQ:CTOR) reporting earnings?
Citius Oncology (CTOR) is scheduled to report earnings on May 21, 2025. The last reported earnings were for reported on February 14, 2025 for Q1.
What were the latest earnings per share (EPS) for Citius Oncology (NASDAQ:CTOR)?
The Actual EPS was $-0.09, which missed the estimate of $0.00.
What were Citius Oncology’s (NASDAQ:CTOR) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.